Nanotechnology Tools for Infection Control

Dr Alessandro Poma is a lecturer in Biomaterials and Allied Subjects in the Division of Biomaterials and Tissue Engineering , Eastman Dental Institute, University College London, UK. His research interests are solid-phase synthesis and applications of MIP NPs able to perform as “synthetic antibodies”; the synthesis of MIP NPs as non-animal antibodies substitutes for influenza virus detection and polymeric systems for drug delivery and biological applications. Dr Loris Rizzello is a Marie Curie Fellow at the Institute for Bioengineering of Catalonia (IBEC), Spain. His research interests are in the field of nanobioengineering, such as nanotechnology tools for antibacterial materials, nanosilver-based antibacterial drugs and devices.

1. introduction
2. The significant drain in antimicrobial discovery by pharma companies
3. Nanoparticles design and production
4. Nanoparticles characterisation and standardisation
5. Principle of body navigation of nanosystems
6. Intracellular fate of nanosystems, their degradation and body accumulation
7. Molecular targets and pharmacodynamics for bactericidal and bacteriostatic activity
8. How to fight bacteria without inducing drug resistance
9. Pre-clinical characterisation: which animal model is best for infection?
10. Clinical translation and envisioned impact of nanotech for infection control: economy, government policy and public awareness